| Literature DB >> 18460189 |
Jamshid Pourazar1, Anders Blomberg, Frank J Kelly, Donna E Davies, Susan J Wilson, Stephen T Holgate, Thomas Sandström.
Abstract
BACKGROUND: Epidemiological studies have demonstrated adverse health effects of environmental pollution. Diesel exhaust (DE) is a major contributor to particulate matter pollution. DE exposure has been shown to induce a pronounced inflammatory response in the airways, together with an enhanced epithelial expression of cytokines such as IL-8, Gro-alpha, IL-13 and activation of redox sensitive transcription factors (NFkappaB, AP-1), and MAP kinases (p38, JNK). The aim of the present investigation was to elucidate the involvement of the epidermal growth factor receptor (EGFR) signalling pathway in the epithelial response to DE in-vivo.Entities:
Year: 2008 PMID: 18460189 PMCID: PMC2405801 DOI: 10.1186/1743-8977-5-8
Source DB: PubMed Journal: Part Fibre Toxicol ISSN: 1743-8977 Impact factor: 9.400
Figure 1Immunostaining. Immunoreactivity within the bronchial epithelium for EGFR after air and diesel exhaust exposure. Positive staining (brown) can be seen on the basolateral border of the columnar cells after exposure to air (panel A) and throughout the epithelium following exposure to diesel exhaust (panel B). Arrows show intracytoplasmatic Tyr 1173 immunostaining in the basoperinuclear region of columnar cells and basolateral border of basal cells (panel C After air exposure and panel D after DE exposure). Panel E: Primary IgG antibody serving as a negative contol. Panel F demonstrates the normal brown DAB staining in panel D which is presented by red color following computer-aided selection and quantification by the image analyser program.
Immunoractivity of investigated antibodies in 15 Air and DE paired subjects participated in study.
| EGFR | 0.240 (0.100–0.370) | 0.690 (0.210–1.960) | |
| Tyr 845 | 0.220 (0.027–0.520) | 0.460 (0.160–1.030) | p = 0.1 |
| Tyr 992 | 0.450 (0.320–0.580) | 0.530 (0.220–1.540) | p = 0.14 |
| Tyr 1068 | 0.015 (0.002–0.250) | 0.180 (0.013–0.550) | p = 0.18 |
| Tyr 1110 | 1.090 (0.560–2.140) | 1.780 (0.980–2.200) | p = 0.39 |
| Tyr 1173 | 2.230 (1.380–2.890) | 3.160 (1.800–5.070) | |
| Tyr 416 | 0.033 (0.001–0.120) | 0.016 (0.003–0.800) | p = 0.13 |
| MEK 1, 2 | 1.330 (0.310–2.670) | 1.410 (0.630–4.440) | p = 0.28 |
| ERK 1, 2 | 0.140 (0.024–0.320) | 0.160 (0.045–0.650) | p = 0.14 |
Two sections from each biopsy and exposure were evaluated during investigation of each antibody.
Bronchial epithelium expression of EGFR, Tyrosine sites and downstream signalling immunoreactivity is given as percentage (%) positively stained area of the total measured epithelial area. All values are quoted as medians with inter-quartile range. Statistical comparisons by Wilcoxon's paired rank test.
Figure 2Description of possible involved signalling pathways. Schematically description of possible involved signalling pathways in the activation and phosphorylation of EGFR, protein tyrosine kinases and downstream signalling following DE exposure. Extended and modified from Puddicombe SM et al. Clinical and Experimental Allergy, 2000, 30, 7–11. The graph is inserted to allow for better understanding of the pathways and mediators discussed in this paper and is by no means conclusive. The yellow box shows the PTK activation pathway through cellular and oxidative stress, cytokine receptors and GPCR. N-SH2 domian in PLC-gamma recognize Tyr 1173 and is primary contributor to PLC-gamma association with the EGFR. Moreover stimulation of various GPCRs such as lysophosphatic acid (LPA) and endothelin-1 (ET-1) rapidly induce phosphorylation of adaptor protein Shc and Shc – Grb2 complex formation. Tyr 1173 on EGFR can function as a docking site for PLC-gamma and PI3-K (green arrow from yellow box). Furthermore Tyr 1173 interact with both SH2 and PTB domains in adoptor protein Shc plays major role in the Ras signalling and subsequence the EGF mediated activation of JNK which is dependent on Shc and controlling JNK activation and possible signalling pathways involved in MEKK1 activation and regulation of JNK and p38 MAPKs after EGF stimulation (red arrows show the signalling direction in the blue box).
Antibodies used for immunohistochemical staining
| EGFR | H11Mouse | 1:140 | EGFR | Dako Glostrup, Denmark |
| P-Tyr 845 | Rabbit | 1:45 | Phosphorylated Tyr 845on EGFR | Cell Signaling Technology, MA, USA |
| P-Tyr 992 | Rabbit | 1:30 | Phosphorylated Tyr 992on EGFR | Cell Signaling Technology, MA, USA |
| P-Tyr 1068 | 1H12Mouse | 1:45 | Phosphorylated Tyr 1068on EGFR | Cell Signaling Technology, MA, USA |
| P-Tyr 1110 | Rabbit | 1:30 | Phosphorylated Tyr 1110on EGFR | Santa Cruz Biotechnology, Santa Cruz, CA, USA |
| P-Tyr 1173 | Rabbit | 1:60 | Phosphorylated Tyr 1173on EGFR | Santa Cruz Biotechnology, Santa Cruz, CA, USA |
| P-Tyr 416 | Rabbit | 1:45 | Phosphorylated Tyr 416on Src family | Cell Signaling Technology, MA, USA |
| P-MEK 1, 2 | Rabbit | 1:40 | Phosphorylated Ser 217/221 | Cell Signaling Technology, MA, USA |
| P-ERK 1, 2 | Rabbit | 1:40 | Phosphorylated Thr 202 and Tyr 204 of human ERK | Cell Signaling Technology, MA, USA |